Lactose (India) Ltd | 134 Cr. | 95.0 | 247/84.3 | 26.0 | 41.7 | 0.00 % | 12.9 % | 9.75 % | 10.0 |
MPS Pharmaa Ltd | 5.27 Cr. | 2.76 | 4.33/2.50 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
Gujarat Themis Biosyn Ltd | 2,663 Cr. | 244 | 390/192 | 50.6 | 20.5 | 0.27 % | 45.0 % | 33.8 % | 1.00 |
Gujarat Terce Laboratories Ltd | 39.9 Cr. | 53.8 | 94.9/44.5 | | 8.73 | 0.00 % | 41.5 % | 14.4 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 41.1 Cr. | 28.0 | 29.1/13.1 | 40.3 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
Godavari Drugs Ltd | 75.0 Cr. | 99.6 | 155/79.0 | 17.1 | 57.6 | 0.00 % | 10.3 % | 10.6 % | 10.0 |
Glenmark Life Sciences Ltd | 41,119 Cr. | 1,457 | 1,831/1,037 | 31.2 | 314 | 0.17 % | 19.4 % | 15.8 % | 1.00 |
Gennex Laboratories Ltd | 316 Cr. | 13.9 | 29.0/11.2 | 19.6 | 8.21 | 0.00 % | 12.5 % | 9.03 % | 1.00 |
Ganga Pharmaceuticals Ltd | 6.44 Cr. | 13.3 | 27.1/9.25 | 80.5 | 14.7 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
Fredun Pharmaceuticals Ltd | 364 Cr. | 772 | 956/635 | 19.4 | 277 | 0.09 % | 17.1 % | 14.3 % | 10.0 |
Fervent Synergies Ltd | 89.1 Cr. | 20.4 | 32.0/14.6 | 30.2 | 11.1 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
Fermenta Biotech Ltd | 918 Cr. | 312 | 449/145 | 12.0 | 123 | 0.40 % | 21.7 % | 23.4 % | 5.00 |
Fabino Enterprises Ltd | 5.20 Cr. | 24.8 | 36.5/22.8 | 40.0 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
Evoq Remedies Ltd | 10.1 Cr. | 4.04 | 12.3/2.11 | 112 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
Everest Organics Ltd | 414 Cr. | 426 | 477/112 | | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
Entero Healthcare Solutions Ltd | 5,224 Cr. | 1,201 | 1,584/991 | 55.1 | 396 | 0.00 % | 8.72 % | 5.64 % | 10.0 |
Murae Organisor Ltd | 165 Cr. | 1.78 | 2.72/1.03 | 22.0 | 2.24 | 0.00 % | 4.21 % | 5.69 % | 2.00 |
Dipna Pharmachem Ltd | 54.0 Cr. | 22.4 | 26.3/6.40 | 65.0 | 15.8 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
Decipher Labs Ltd | 12.0 Cr. | 11.8 | 24.6/10.0 | | 22.6 | 0.00 % | 28.4 % | 22.7 % | 10.0 |
Coral Laboratories Ltd | 259 Cr. | 725 | 999/465 | 10.5 | 563 | 0.28 % | 17.4 % | 13.1 % | 10.0 |
Concord Drugs Ltd | 31.5 Cr. | 31.5 | 45.0/26.1 | 105 | 34.1 | 0.00 % | 4.83 % | 0.88 % | 10.0 |
Colinz Laboratories Ltd | 28.7 Cr. | 62.8 | 88.7/36.0 | 57.4 | 20.7 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
Cian Healthcare Ltd | 9.57 Cr. | 3.83 | 26.5/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 21.3 Cr. | 142 | 154/55.1 | 62.6 | 87.6 | 0.00 % | 3.78 % | 2.62 % | 10.0 |
Checkpoint Trends Ltd | 10.8 Cr. | 19.7 | 28.9/6.08 | 359 | 1.02 | 0.00 % | 9.17 % | 5.50 % | 10.0 |
Chandra Bhagat Pharma Ltd | 42.2 Cr. | 56.0 | 114/46.2 | 49.1 | 39.7 | 0.00 % | 6.48 % | 2.92 % | 10.0 |
Brawn Biotech Ltd | 5.13 Cr. | 17.1 | 27.8/15.5 | | 11.2 | 0.00 % | 42.5 % | 42.8 % | 10.0 |
Blue Jet Healthcare Ltd | 15,695 Cr. | 905 | 969/347 | 51.4 | 65.3 | 0.11 % | 40.6 % | 30.8 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 110 Cr. | 25.6 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 9.35 Cr. | 18.4 | 46.0/17.4 | 16.1 | 18.7 | 0.00 % | 10.1 % | 6.30 % | 10.0 |
BDH Industries Ltd | 143 Cr. | 248 | 418/241 | 15.4 | 119 | 1.81 % | 17.8 % | 14.2 % | 10.0 |
Bacil Pharma Ltd | 24.5 Cr. | 41.6 | 62.6/14.8 | 61.2 | 43.2 | 0.00 % | 3.05 % | 3.00 % | 10.0 |
Aurobindo Pharma Ltd | 67,254 Cr. | 1,148 | 1,593/994 | 19.3 | 557 | 0.39 % | 14.3 % | 11.2 % | 1.00 |
Auro Laboratories Ltd | 154 Cr. | 248 | 298/156 | 84.0 | 69.0 | 0.00 % | 3.79 % | 4.33 % | 10.0 |
Anuh Pharma Ltd | 1,055 Cr. | 210 | 250/148 | 22.3 | 65.1 | 1.19 % | 19.5 % | 15.3 % | 5.00 |
ANG Lifesciences India Ltd | 38.0 Cr. | 29.1 | 62.8/21.0 | | 51.2 | 0.00 % | 4.12 % | 14.4 % | 10.0 |
Ami Organics Ltd | 9,630 Cr. | 1,176 | 1,322/504 | 60.7 | 160 | 0.13 % | 19.9 % | 16.0 % | 5.00 |
Amerise Biosciences Ltd | 5.55 Cr. | 0.84 | 1.45/0.55 | 555 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 290 Cr. | 37.9 | 77.7/34.1 | 29.0 | 18.3 | 0.00 % | 8.60 % | 7.23 % | 10.0 |
Adline Chem Lab Ltd | 8.55 Cr. | 14.6 | 26.0/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 78.4 Cr. | 3.33 | 6.25/2.82 | 143 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
Abbott India Ltd | 64,717 Cr. | 30,455 | 31,900/25,260 | 45.8 | 1,992 | 1.35 % | 46.2 % | 35.7 % | 10.0 |
Aarti Pharmalabs Ltd | 8,257 Cr. | 911 | 918/496 | 30.3 | 220 | 0.33 % | 17.4 % | 14.5 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 153 Cr. | 54.1 | 75.8/31.3 | 38.1 | 47.8 | 0.00 % | 6.17 % | 3.03 % | 10.0 |
Zota Health Care Ltd | 2,941 Cr. | 999 | 1,078/440 | | 78.1 | 0.10 % | 17.0 % | 36.0 % | 10.0 |
Wockhardt Ltd | 23,809 Cr. | 1,465 | 1,680/489 | | 268 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
Wanbury Ltd | 974 Cr. | 297 | 330/131 | 31.9 | 18.1 | 0.00 % | 34.9 % | 70.0 % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.11 % | % | 2.00 |
Venus Remedies Ltd | 582 Cr. | 435 | 440/270 | 14.9 | 420 | 0.00 % | 11.4 % | 7.45 % | 10.0 |
Unichem Laboratories Ltd | 4,212 Cr. | 598 | 950/501 | 30.6 | 348 | 0.00 % | 6.36 % | 5.71 % | 2.00 |
TTK Healthcare Ltd | 1,717 Cr. | 1,215 | 1,923/991 | 24.1 | 754 | 0.82 % | 9.25 % | 6.89 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,07,441 Cr. | 3,175 | 3,591/2,570 | 55.7 | 224 | 1.01 % | 27.2 % | 26.7 % | 5.00 |
Themis Medicare Ltd | 1,249 Cr. | 136 | 317/115 | 41.9 | 43.7 | 0.37 % | 10.4 % | 7.65 % | 1.00 |
Syncom Formulations (India) Ltd | 2,076 Cr. | 22.1 | 27.9/11.0 | 42.5 | 3.62 | 0.00 % | 18.7 % | 15.6 % | 1.00 |
Suven Pharmaceuticals Ltd | 27,473 Cr. | 1,079 | 1,360/597 | 98.5 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
Suven Life Sciences Ltd | 5,340 Cr. | 245 | 257/83.0 | | 5.04 | 0.00 % | 84.4 % | 84.6 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 4,02,512 Cr. | 1,678 | 1,960/1,377 | 35.1 | 301 | 0.80 % | 20.2 % | 16.9 % | 1.00 |
Solara Active Pharma Sciences Ltd | 2,119 Cr. | 481 | 886/367 | 3,924 | 304 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
SMS Pharmaceuticals Ltd | 2,347 Cr. | 265 | 398/175 | 34.3 | 75.9 | 0.15 % | 12.2 % | 11.0 % | 1.00 |
SMS Lifesciences India Ltd | 396 Cr. | 1,308 | 1,750/681 | 21.1 | 650 | 0.11 % | 11.8 % | 10.0 % | 10.0 |
Shilpa Medicare Ltd | 8,815 Cr. | 901 | 960/418 | 98.5 | 243 | 0.00 % | 7.94 % | 4.28 % | 1.00 |
Sequent Scientific Ltd | 4,802 Cr. | 192 | 241/91.8 | 217 | 28.1 | 0.00 % | 8.97 % | 3.25 % | 2.00 |
Sanofi India Ltd | 14,261 Cr. | 6,192 | 7,600/4,146 | 37.6 | 374 | 1.89 % | 49.2 % | 47.2 % | 10.0 |
RPG Life Sciences Ltd | 3,607 Cr. | 2,181 | 2,977/1,381 | 30.5 | 321 | 0.73 % | 33.3 % | 26.1 % | 8.00 |
Procter & Gamble Health Ltd | 9,541 Cr. | 5,748 | 5,944/4,641 | 36.7 | 323 | 1.39 % | 45.0 % | 33.5 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 218 Cr. | 61.9 | 87.5/31.9 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
Pfizer Ltd | 25,680 Cr. | 5,613 | 6,453/3,701 | 40.1 | 922 | 0.62 % | 21.6 % | 16.4 % | 10.0 |
Par Drugs & Chemicals Ltd | 124 Cr. | 101 | 348/81.0 | 9.31 | 80.4 | 0.00 % | 19.5 % | 14.5 % | 10.0 |
Panacea Biotec Ltd | 3,249 Cr. | 530 | 582/112 | | 136 | 0.00 % | 4.68 % | 5.03 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 3,189 Cr. | 629 | 1,998/604 | 32.0 | 250 | 0.00 % | 8.02 % | 8.18 % | 10.0 |
Neuland Laboratories Ltd | 14,758 Cr. | 11,503 | 18,100/5,540 | 72.8 | 1,188 | 0.12 % | 18.2 % | 14.4 % | 10.0 |
Nectar Lifescience Ltd | 609 Cr. | 27.1 | 56.5/20.0 | 35.8 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
Natco Pharma Ltd | 15,823 Cr. | 883 | 1,639/660 | 8.40 | 425 | 1.08 % | 32.8 % | 28.0 % | 2.00 |
Morepen Laboratories Ltd | 3,553 Cr. | 64.8 | 101/41.7 | 30.1 | 21.1 | 0.00 % | 15.1 % | 11.8 % | 2.00 |
Marksans Pharma Ltd | 11,847 Cr. | 261 | 359/130 | 31.1 | 54.4 | 0.23 % | 20.1 % | 16.8 % | 1.00 |
Mangalam Drugs and Organics Ltd | 126 Cr. | 79.5 | 145/70.1 | 18.2 | 93.9 | 0.00 % | 8.20 % | 4.76 % | 10.0 |
Lyka Labs Ltd | 434 Cr. | 122 | 177/90.2 | 54.8 | 29.0 | 0.00 % | 9.93 % | 9.24 % | 10.0 |
Lupin Ltd | 89,392 Cr. | 1,958 | 2,403/1,493 | 27.2 | 377 | 0.41 % | 21.5 % | 20.8 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,086 Cr. | 542 | 980/498 | 13.2 | 335 | 0.33 % | 17.6 % | 13.0 % | 10.0 |
Laurus Labs Ltd | 32,873 Cr. | 610 | 661/385 | 86.4 | 84.6 | 0.20 % | 10.4 % | 8.67 % | 2.00 |
Kwality Pharmaceuticals Ltd | 924 Cr. | 890 | 1,070/481 | 23.2 | 256 | 0.00 % | 18.3 % | 16.2 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 162 Cr. | 75.4 | 129/60.3 | | 67.8 | 0.00 % | 29.9 % | % | 10.0 |
Kopran Ltd | 884 Cr. | 183 | 370/155 | 22.9 | 107 | 1.64 % | 9.75 % | 7.64 % | 10.0 |
Kilitch Drugs (India) Ltd | 709 Cr. | 441 | 500/271 | 28.4 | 126 | 0.00 % | 17.3 % | 13.2 % | 10.0 |
Jubilant Pharmova Ltd | 18,699 Cr. | 1,174 | 1,310/617 | 33.7 | 393 | 0.43 % | 9.54 % | 9.50 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 26,107 Cr. | 1,676 | 2,030/1,303 | 39.6 | 221 | 0.73 % | 26.6 % | 20.8 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,573 Cr. | 237 | 328/109 | 39.6 | 36.1 | 0.84 % | 23.0 % | 18.6 % | 2.00 |
Ipca Laboratories Ltd | 36,148 Cr. | 1,425 | 1,758/1,052 | 41.7 | 274 | 0.28 % | 15.0 % | 13.1 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 2,581 Cr. | 87.9 | 108/57.5 | 25.6 | 57.5 | 1.14 % | 8.85 % | 6.12 % | 2.00 |
Ind-Swift Ltd | 85.0 Cr. | 15.7 | 34.7/12.0 | 1.32 | 122 | 0.00 % | 13.4 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 492 Cr. | 81.2 | 186/67.2 | 5.95 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
Indoco Remedies Ltd | 2,312 Cr. | 251 | 388/190 | | 111 | 0.60 % | 0.48 % | 7.00 % | 2.00 |
Hikal Ltd | 4,589 Cr. | 372 | 465/267 | 50.5 | 102 | 0.32 % | 9.87 % | 7.41 % | 2.00 |
Hester Biosciences Ltd | 1,524 Cr. | 1,791 | 3,379/1,243 | 55.4 | 369 | 0.33 % | 9.62 % | 9.07 % | 10.0 |
Gufic BioSciences Ltd | 3,921 Cr. | 391 | 504/278 | 56.1 | 60.0 | 0.03 % | 13.0 % | 12.3 % | 1.00 |
Granules India Ltd | 12,868 Cr. | 531 | 725/401 | 26.8 | 153 | 0.28 % | 15.1 % | 13.8 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 41,119 Cr. | 1,457 | 1,831/1,037 | 31.2 | 314 | 0.17 % | 19.4 % | 15.8 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 55,880 Cr. | 3,299 | 3,398/1,921 | 60.5 | 115 | 1.27 % | 66.9 % | 49.6 % | 10.0 |
Gland Pharma Ltd | 26,173 Cr. | 1,589 | 2,221/1,200 | 24.0 | 592 | 1.26 % | 15.9 % | 11.6 % | 1.00 |
FDC Ltd | 7,146 Cr. | 439 | 659/359 | 26.8 | 140 | 1.14 % | 16.4 % | 12.2 % | 1.00 |
ERIS Lifesciences Ltd | 21,542 Cr. | 1,582 | 1,664/816 | 61.2 | 210 | 0.46 % | 12.2 % | 12.9 % | 1.00 |
Dr Reddys Laboratories Ltd | 1,04,407 Cr. | 1,251 | 1,421/1,020 | 18.5 | 402 | 0.64 % | 23.1 % | 18.3 % | 1.00 |
Dishman Carbogen Amcis Ltd | 4,175 Cr. | 266 | 308/133 | | 372 | 0.00 % | 2.44 % | 0.34 % | 2.00 |
Cipla Ltd | 1,18,376 Cr. | 1,466 | 1,702/1,310 | 22.5 | 386 | 0.89 % | 23.3 % | 18.2 % | 2.00 |
Caplin Point Laboratories Ltd | 16,362 Cr. | 2,153 | 2,641/1,221 | 30.5 | 375 | 0.23 % | 25.8 % | 21.7 % | 2.00 |
Brooks Laboratories Ltd | 422 Cr. | 143 | 203/72.5 | | 33.3 | 0.00 % | 9.90 % | 12.2 % | 10.0 |
Bliss GVS Pharma Ltd | 1,380 Cr. | 131 | 186/92.2 | 16.4 | 99.7 | 0.38 % | 11.7 % | 8.36 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 80.1 Cr. | 49.2 | 92.0/40.4 | 143 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
Biocon Ltd | 40,322 Cr. | 336 | 405/270 | 41.9 | 180 | 0.15 % | 6.13 % | 4.64 % | 5.00 |
Beta Drugs Ltd | 1,902 Cr. | 1,884 | 2,215/1,048 | 41.5 | 195 | 0.00 % | 27.3 % | 25.8 % | 10.0 |
Bal Pharma Ltd | 155 Cr. | 97.2 | 158/76.3 | 21.4 | 48.6 | 1.23 % | 10.1 % | 9.84 % | 10.0 |
Bafna Pharmaceuticals Ltd | 177 Cr. | 75.0 | 96.0/67.8 | 28.2 | 35.8 | 0.00 % | 8.28 % | 7.61 % | 10.0 |
Astrazeneca Pharma India Ltd | 19,930 Cr. | 7,972 | 9,211/5,416 | 114 | 308 | 0.30 % | 33.4 % | 23.6 % | 2.00 |
Amrutanjan Health Care Ltd | 2,058 Cr. | 712 | 863/544 | 40.5 | 113 | 0.65 % | 22.4 % | 16.5 % | 1.00 |
Alpa Laboratories Ltd | 209 Cr. | 99.1 | 145/69.9 | 10.6 | 86.4 | 0.00 % | 15.0 % | 11.4 % | 10.0 |
Alkem Laboratories Ltd | 60,960 Cr. | 5,098 | 6,440/4,407 | 28.2 | 1,002 | 0.78 % | 20.4 % | 19.4 % | 2.00 |
Alembic Pharmaceuticals Ltd | 20,011 Cr. | 1,018 | 1,304/725 | 35.0 | 264 | 1.08 % | 13.1 % | 11.4 % | 2.00 |
Albert David Ltd | 458 Cr. | 802 | 1,754/763 | 26.6 | 688 | 1.43 % | 6.48 % | 4.44 % | 10.0 |
Ajanta Pharma Ltd | 31,363 Cr. | 2,511 | 3,486/2,022 | 34.1 | 290 | 1.43 % | 33.3 % | 25.6 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,413 Cr. | 305 | 571/258 | 26.0 | 127 | 1.31 % | 13.0 % | 9.55 % | 2.00 |
Aarti Drugs Limited | 4,081 Cr. | 444 | 635/312 | 25.9 | 136 | 0.23 % | 13.4 % | 13.0 % | 10.0 |
Industry Average | 18,354.98 Cr | 1,129.60 | | 88.53 | 194.54 | 0.32% | 16.70% | 15.22% | 6.19 |